Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by itntdf


T.ONC

RE:Toilet Market day 2

so, you're saying you have an issue with kaszanka?

December 16, 2022

T.ONC

RE:RE:RE:RE:Defying gravity

certainly no rush to the door.  haven't even traded at the avg...

December 15, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Over 4M options to the board...

https://pancan.org/news/another-fda-treatment-approval-underscores-promise-of...

December 15, 2022

T.ONC

RE:RE:RE:Interim Datas and speculations

here's the link for the sec filing re: adlai agreement with oncy. ...

December 13, 2022

T.ONC

RE:RE:RE:RE:RE:Time is running out...

Currently, the cost of human genome editing therapies ranges between $373,000...

December 13, 2022

T.ONC

RE:RE:RE:RE:RE:Time is running out...

sequencing a gene is not the same as editing a gene.  got any new...

December 13, 2022

T.ONC

RE:Interim Datas and speculations

don't believe adlai needs a "second" licensing deal.  they...

December 13, 2022

T.ONC

RE:RE:RE:Time is running out...

gene edited "cures" are much more of an individual approach and...

December 13, 2022

T.ONC

A wider net could help sweep up oncy

A customized Moderna Inc. MRNA -6.89%decrease; red down...

December 13, 2022

T.ONC

RE:RE:Amgen to acquire Horizon Therapeutics for US$26.4 Billion

yes, and "amam" was $0.41 around the close last thursday and shot...

December 12, 2022

T.ONC

RE:RE:BP has money to burn

sorry you seem to have a reading and comprehension problem.  maybe re...

December 12, 2022

T.ONC

BP has money to burn

Amgen Inc. AMGN -2.42%decrease; red down pointing triangle has...

December 12, 2022

T.ONC

RE:RE:RE:RE:usa newsgroup article re: pela and pancreatic cancer

self-promotion doesn't necessarily equate to no self-respect.  don...

December 11, 2022

T.ONC

RE:RE:usa newsgroup article re: pela and pancreatic cancer

there is a fake it til you make it component of paid advertising but that'...

December 11, 2022

T.ONC

usa newsgroup article re: pela and pancreatic cancer

https://usanewsgroup.com/2022/11/27/market-uncertainty-is-creating...

December 11, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval after Bracelet-1

note the astrazeneca relationship with the adlai nortye associate at tomorrow...

December 6, 2022

T.ONC

san antonio breast cancer symposium

awaiting for update on the following: 12/7/2022 5:00 PM - 6:15 PM P3...

December 6, 2022

T.ONC

RE:RE:RE:RE:RE:The pressure is on for Big Pharma...& Onc.

remember that oncy sold exclusive rights to pela to adlai nortye which covers...

December 4, 2022

T.ONC

roche burning candle at both ends

roche also partnering with biontech in pancreatic cancer.  however, that...

December 1, 2022

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

ok, you caught me.  we have been monitoring this site from the dark side...

November 21, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next

Featured Company